openfor.co_logo_V1.8-transparent.png

Leaps by Bayer

Biotechnology investors

Germany

Overview

Website

Headquarter

Germany

Team Size

11-50

Industry

Venture Capital & Private Equity

Founded

2015

End User

B2B

Specialties

Research, Biotechnology, Breakthrough innovation, Innovation, Scientific breakthroughs in healthcare and agriculture, Investment, Partnership, and Venture Capital

Company Introduction

Leaps by Bayer is spearheading a movement to make paradigm-shifting advances in the life sciences – targeting the breakthroughs that could fundamentally change the world for the better. Much of what we are aiming to achieve is not yet possible. Leaps by Bayer was created in 2015 to break boundaries in life sciences investment—in scale, risk, collaboration, and mission. Through our ambitious 10 leaps, we accept that the risk of failure is very high. But in order to push beyond what is considered possible, we need to go beyond industry conventions for inspiration and explore radically new approaches.

Background

Leaps by Bayer was created in 2015 to break boundaries in life sciences investment—in scale, risk, collaboration, and mission. Through our ambitious 10 leaps, we accept that the risk of failure is very high. But in order to push beyond what is considered possible, we need to go beyond industry conventions for inspiration and explore radically new approaches.

The passion to push our limits lies within people, not companies. We are inspired by people who take leaps – from the scientists dedicating their lives to potential breakthrough technologies to individuals who defy their physical limits.

In the spirit of collaborating with the brightest minds in the life sciences, we celebrate the stories of people taking leaps, as they speak for all of us.

""Growing knowledge through collaboration.""

Currently industry convention blocks innovation by keeping IP siloed. We believe this can hinder scientific breakthroughs. We challenge this convention by enabling the exchange of proprietary assets. This can include sharing our own patents or providing access to the Bayer network’s technical capabilities and 150 years of expertise. All of the companies we partner with remain autonomous with respect to decision making, we build our relationship from start to finish.

We do so by facilitating and supporting them in a process we call “active incubation”. Experienced team members actively engage in the young companies’ development by providing resources and helping them to steer the initial strategic direction.

Highlights

- Has 150 years of expertise in human health and agriculture
- Nearly 40 investments in health and agriculture fields

[Health Sector Portfolios]
- Ada Health
- Edifice Health
- Senti Bio
- Metagenomi
- Azitra
- 15+ More

[Agriculture Sector Portfolios]
- Guardian
- Ukko
- Rantizo
- Unfold
- Apollo Agriculture
- 11+ More"

Collaboration Opportunities

Partnership Types:

Co-Branding, PoC, Co-Product

Target Locations:

Anywhere in the world

"We believe ""Growing knowledge through collaboration."
We are looking forward the technology company to work with in the following sectors around the world.

[Project Fields]
- Health
- Agriculture"

Gallery

Add a Title
Add a Title
Add a Title
Add a Title
Add a Title
Add a Title

Lead

Lead

Jürgen Eckhardt

General Director

Type of Partnership

Join our community and start building partnerships opportunities for your company.